Expression and purification of the 26 kDa periplasmic protein of Brucella abortus: a reagent for the diagnosis of bovine brucellosis.

Expression and purification of the 26 kDa periplasmic protein of Brucella abortus: a reagent for the diagnosis of bovine brucellosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Expression and purification of the 26 kDa periplasmic protein of Brucella abortus: a reagent for the diagnosis of bovine brucellosis. Abstract Text:

Sanjay Kumar,Urmil Tuteja,Ashok Kumar,Harsh Vardhan Batra,Sanjay Kumar,Urmil Tuteja,Ashok Kumar,Harsh Vardhan Batra,

Expression and purification of the 26 kDa periplasmic protein of Brucella abortus: a reagent for the diagnosis of bovine brucellosis. Publishing Authors By Initials

S Kumar,U Tuteja,A Kumar,HV Batra,S Kumar,U Tuteja,A Kumar,HV Batra,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Expression and purification of the 26 kDa periplasmic protein of Brucella abortus: a reagent for the diagnosis of bovine brucellosis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Biotechnology and applied biochemistry

VOLUME: 49

Page Numbers: 213-8

Journal Abbreviation:

ISSN: 1470-8744

DAY: 14

MONTH: Mar

YEAR: 2008

Expression and purification of the 26 kDa periplasmic protein of Brucella abortus: a reagent for the diagnosis of bovine brucellosis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8609465

Expression and purification of the 26 kDa periplasmic protein of Brucella abortus: a reagent for the diagnosis of bovine brucellosis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Expression and purification of the 26 kDa periplasmic protein of Brucella abortus: a reagent for the diagnosis of bovine brucellosis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Expression and purification of the 26 kDa periplasmic protein of Brucella abortus: a reagent for the diagnosis of bovine brucellosis.

AFFILIATION:

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Biotechnol Appl Biochem

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Expression and purification of the 26 kDa periplasmic protein of Brucella abortus: a reagent for the diagnosis of bovine brucellosis Related Publications

• Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125).
• Alternate splicing at the 3'-end of the human pancreatic tumor-associated mucin MUC4 cDNA.
• Cigarette smoke-induced differential expression of the genes involved in exocrine function of the rat pancreas.
• Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells.
• Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies.
• Development of a real-time PCR assay for the diagnosis of scrub typhus cases in India and evidence of the prevalence of new genotype of O. tsutsugamushi.
• Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy.
• Engineering antibodies for clinical applications.
• Expression of TAG-72 in ovarian cancer and its correlation with tumor stage and patient prognosis.
• Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans.
• Generation and characterization of murine monoclonal antibodies to recombinant 26-kDa periplasmic protein of Brucella abortus.
• Human MUC4 mucin cDNA and its variants in pancreatic carcinoma.
• Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells.
• IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-gamma response.
• Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
• Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies.
• MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms.
• MUC4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGFbeta2.
• MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
• MUC4-expressing pancreatic adenocarcinomas show elevated levels of both T1 and T2 cytokines: potential pathobiologic implications.
• Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
• Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy.
• Optimization of radioimmunotherapy of solid tumors: biological impediments and their modulation.
• Purification and characterization of a human pancreatic adenocarcinoma mucin.
• Retinoic acid-dependent transforming growth factor-beta 2-mediated induction of MUC4 mucin expression in human pancreatic tumor cells follows retinoic acid receptor-alpha signaling pathway.
• Sensitive and rapid liquid chromatography/tandem mass spectrometric assay for the quantification of piperaquine in human plasma.
• Simultaneous direct detection of toxigenic and non-toxigenic Vibrio cholerae from rectal swabs and environmental samples by sandwich ELISA.
• Spotted fevers & typhus fever in Tamil Nadu.
• Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies.
• [Hydroxy(tosyloxy)iodo]benzene mediated alpha-azidation of ketones.